论文部分内容阅读
[目的]探讨肺癌术后再次肺切除的临床价值。[方法]回顾7例肺癌术后患者再次手术治疗的临床资料,分析手术难度及术后恢复情况并总结治疗经验,随访分析全组病例生存情况。[结果]7例肺癌术后患者均为完全切除病灶,无术中及围术期死亡。7例胸膜腔粘连均严重,尤其肺门处肿瘤生长、浸润严重,3例患者肺门大血管破裂出血500ml以上。手术时间和术中出血量明显超出初次手术(P=0.000)。术后发生心、肺功能不全各1例,短期支气管胸膜瘘、伤口感染各1例。全组1年、2年生存率分别为50.0%和16.7%。[结论]虽然肺部肿瘤再次手术的难度和风险增大,但其成功率仍然很高,只要掌握好手术指征,再次手术仍然能够获得满意疗效。
[Objective] To investigate the clinical value of resectable lung cancer after lung cancer surgery. [Methods] The clinical data of 7 cases of reoperation after lung cancer surgery were retrospectively analyzed. The difficulty of operation and postoperative recovery were analyzed and the treatment experience was summarized. The survival of the whole group was followed up. [Results] All the 7 patients with lung cancer underwent complete resection of the lesion without any intraoperative and perioperative deaths. 7 cases of pleural cavity adhesions are serious, especially in the hilar tumor growth, severe infiltration, hilar large vessels in 3 patients with bleeding 500ml or more. The operation time and intraoperative blood loss significantly exceeded the initial surgery (P = 0.000). Postoperative heart and lung dysfunction in 1 case, short-term bronchopleural fistula, wound infection in 1 case. The 1-year, 2-year overall survival rates were 50.0% and 16.7%. [Conclusion] Although the difficulty and risk of reoperation of pulmonary neoplasm increased, its success rate is still high. As long as the operation indications are mastered, reoperation can still get satisfactory curative effect.